Atika Capital Management »

Dianthus Therapeutics shares owned by Atika Capital Management

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Atika Capital Management from 13F filings

Historical chart of Atika Capital Management investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Atika Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Atika Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.5M 135k 41.21

More positions owned by Atika Capital Management

Robinhood Mkts Com Cl A Put Option (HOOD)
Spdr Series Trust State Street Spd Put Option (XBI)
Vertiv Holdings Com Cl A (VRT)
Eli Lilly & Co. (LLY)
Intuitive Surgical Com New (ISRG)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Shopify Cl A Sub Vtg Shs (SHOP)
Madrigal Pharmaceuticals (MDGL)
Bwx Technologies (BWXT)
Amazon (AMZN)
Cogent Biosciences (COGT)
Netflix (NFLX)
Talen Energy Corp (TLN)
Seagate Technology Hldngs Ord Shs (STX)

View all positions for Atika Capital Management

Top funds holding Dianthus Therapeutics

FMR
RA Capital Management
Wellington Management Company
Octagon Capital Advisors
Fairmount Funds Management
Avidity Partners Management
Vanguard Group
BlackRock
TCG Crossover Management
State Street Corporation
Braidwell
Point72 Asset Management
Citadel Advisors
Marshall Wace
Polar Capital Holdings

View all funds holding Dianthus Therapeutics